Moxisylyte hydrochloride

Cat. No.: 0225LY-1220

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Moxisylyte hydrochloride functions as an alpha-adrenergic blocking agent specifically utilized in the treatment of Raynaud's disease.

Synonym: Thymoxamine hydrochloride; 964-52-3; Moxisylyte; Thymoxamine; Carlytene; Moxilite; Moxisylyt; Vasoklin; Acetoxythymoxamine; Timoxamina; Arlytene; Opilon; Sympal; Moxisylytum; Moxisilita; (2-(4-Acetoxy-2-isopropyl-5-methylphenoxy)ethyl)dimethylamine; 4-(2-(Dimethylamino)ethoxy)-5-isopropyl-2-methylphenyl acetate; 4-Dimethylaminoethoxycarvacrol; Phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester); Carvacrol, 5-(2-(dimethylamino)ethoxy)-, acetate (ester); 6-Acetoxythymol 2-(dimethylamino)ethyl ether; Thymoxyalcylamine; 4-(2-(Dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)phenol acetate (ester); Thymoxamine hcl; ((6-Acetoxythymoxy)ethyl)dimethylamine

CAS No.: 964-52-3

Compound CID: 4260

Formula: C₁₆H₂₆ClNO₃

Formula Weight: 315.84

Specification

Relative Density: 1.018 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Moxisylyte hydrochloride can be used in vascular research to study the selective antagonism of alpha-adrenergic receptors and their vasodilatory effects.